COP26: GSK becomes Principal Partner for climate change summit

The pharmaceutical company is the ninth Principal Partner that will support the delivery of a successful and ambitious COP26, driving action on climate, nature and health targets in support of the summit’s ambitions

Advil aims to reduce plastics in 80m bottles by 20%

The ‘first-of-its-kind’ material that will be used is expected to reduce the amount of plastics by nearly 500,000 pounds

Wind energy powers Boehringer Ingelheim’s largest US manufacturing site

It has signed a 10-year contract with Evergy for energy generated at a wind farm in Kansas for its site in St. Joseph, Missouri

COP26: Dettol maker Reckitt announced as Principal Partner for climate summit

Reckitt has already committed to science-based targets to meet the Paris climate agreement by 2030, aims to power all its operations with 100% renewable electricity by 2030 and become carbon neutral by 2040

future Net Zero Standard with Carbon Expert joins UN’s Race to Zero

Race to Zero aims to mobilise groups and organisations outside of national governments to send a signal that businesses, cities and investors are united in meeting the Paris Agreement’s goals

Icelandic firm Össur to become carbon neutral in 2021

The company, which manufactures orthopaedics equipment, including prosthetics, says it will achieve the goal for energy and fuel consumption, waste generation as well as business travel

Pharma company Lundbeck inks PPA for solar power with Better Energy

Under the agreement, Better Energy will build a new solar park in Guldborgsund Municipality in Denmark and provide the electricity generated to Lundbeck

Amgen to invest $200m to become carbon-neutral by 2027

The biopharmaceutical company has also set targets to reduce water consumption by 40% and waste disposed by 75%

‘Beer saved grains could help protect coral reefs’

That’s the suggestion from Claudia Condulet, Founder of the startup BELLEJO, who spoke to FNZ about the way wasted biomass can be transformed into cosmetics products

Novartis signs 63MW clean energy PPA with EDP Renewables

The pharmaceutical giant will receive electricity from a wind farm and a solar project in Spain